Combining immunomodulators with biologic therapies vs. biologic monotherapy in patients with inflammatory bowel diseases: Target trial emulations

Authors
Category Primary study
JournalTher. Adv. Gastroenterol.
Year 2026
This article has no abstract
Epistemonikos ID: 0220b58b95fff5e5ddc5efa5ebbac58d7483d080
First added on: Oct 24, 2026